Miragen Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $288k | 17k | 17.51 |
| 2023-09-30 | $1.3M | 85k | 15.34 |
| 2023-06-30 | $1.8M | 75k | 23.79 |
| 2023-03-31 | $1.6M | 64k | 25.44 |
| 2022-12-31 | $1.9M | 67k | 29.21 |
| 2022-09-30 | $1.7M | 82k | 20.51 |
| 2022-06-30 | $398k | 34k | 11.57 |
| 2022-03-31 | $370k | 20k | 18.50 |